The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

STERIS’ Healthcare segment is gaining from the successful market adoption of its comprehensive offerings, including infection prevention consumables and capital equipment. Further, its services to ...

Revenue exceeded forecasts by 0.63%, reaching $1.6 billion. EPS was slightly below expectations at $2.83, missing by $0.02. The stock fell by 2.17% in premarket trading, indicating cautious investor ...

STERIS plc, a leading provider of infection prevention and procedural products and services, has demonstrated resilience in the face of economic challenges while maintaining a strong market position.

STERIS' STE strong rebound of procedure volumes in the United States is leading to solid growth in the Healthcare business. The company carries a Zacks Rank #2 (Buy) at present. STERIS’ Healthcare ...

STERIS’ STE strong rebound of procedure volumes in the United States is leading to solid growth in the Healthcare business. Yet, a fiercely competitive market offsets the positive. The stock carries a ...

STERIS plc’s STE Healthcare business continues to benefit from robust U.S. procedure volumes, favorable pricing and market share gains. Service revenues fuel the Applied Sterilization Technologies ...